THE PREVENTION AND TREATMENT OF NEONATAL INFECTIOUS AND INFLAMMATORY DISEASES CAUSED BY GROUP B STREPTOCOCCUS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The given review considers an update on the epidemiology, clinical presentation, prevention, and treatment of neonatal infectious and inflammatory diseases caused by group B streptococcus. It is shown that despite their reduced incidence and the proven eff icacy of prophylactic antibiotics in the mother during labor, the problem does not lose its relevance. At the present time, there is a need to develop national guidelines based on current diagnostic techniques, including molecular biological studies, and on the analysis the efficiency of therapy regimens used to reduce adverse obstetric and perinatal outcomes.

Full Text

Restricted Access

About the authors

V. V ZUBKOV

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: victor.zubkov@mail.ru
Moscow

I. I RYUMINA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: i_ryumina@oparina4.ru
Moscow

V. L TYUTYUNNIK

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: tioutiounnik@mail.ru
Moscow

N. E KAN

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: kan-med@mail.ru
Moscow

References

  1. Schuchat A., Zywicki S.S., Dinsmoor M.J., Mercer B., Romaguera J., O’Sullivan M.J. et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics. 2000; 105(1,Pt1): 21-6.
  2. Министерство здравоохранения и медицинской промышленности Российской Федерации. Санкт-Петербургская Государственная Медицинская Академия им. И.И. Мечникова. Эпидемиология и профилактика заболеваний, вызываемых стрептококком группы В, у новорожденных. Информационное письмо. СПб.; 1999.
  3. Шухов В.С., Рюмина И.И., Зубков В.В. Антимикробная терапия распространенных заболеваний у детей. М.: Боргес; 2011. 185 с.
  4. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee Opinion No. 485: Prevention of early-onset group B streptococcal disease in newborns. Obstet. Gynecol. 2011; 117(4): 1019-27.
  5. Van den Hoogen A., Gerards L.J., Verboon-Maciolek M.A., Fleer A., Krediet T.G. Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology. 2010; 97(1): 22-8.
  6. Yudin M.H., Van Schalkwyk J., Van Eyk N, Boucher M., Castillo E, Cormier B. et al.; Society of Obstetricians and Gynaecologists of Canada. Antibiotic therapy in preterm premature rupture of the membranes. J. Obstet. Gynaecol. Can. 2009; 31(9): 863-74.
  7. Beal S., Dancer S. Antenatal prevention of neonatal group B streptococcal infection. Gynaecol. Perinat. Pract. 2006; 6: 218-25.
  8. Ho M.Y., Wu C.T., Huang F.Y., Peng C.C. Group B streptococcal infections in neonates: an 11-year review. Acta Paediatr. Taiwan. 1999; 40(2): 83-6.
  9. Николаева И.В. Стрептококковая инфекция у новорожденных и грудных детей. Лечащий врач. 2012; 1: 36-9.
  10. Prevention of Perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Recomm. Rep. 1996; 45(RR-7): 1-24.
  11. Gerard P., Verghote-D’Hulst M., Bachy A., Duhaut G. Group B streptococcal colonization of pregnant women and their neonates. Epidemiological study and controlled trial of prophylactic treatment of the newborn. Acta Paediatr. Scand. 1979; 68: 819-23.
  12. Verani J.R., McGee L., Schrag S.J. Prevention of perinatal group B streptococcal disease - revised guidelines from CDC, 2010. MMWR Recomm. Rep. 2010; 59(RR-10): 1-36.
  13. Ungerer R.L.S., Lincetto O., McGuire W., Saloojee H., Gulmezoglu A.M. Prophylactic versus selective antibiotics for term newborn infants of mothers with risk factors for neonatal infection. Cochrane Database Syst. Rev. 2004; (4): CD003957.
  14. Baker C.J. Group B streptococcal infections. Clin. Perinatol. 1997; 24: 59-70.
  15. Zaleznik D.F., Rench M.A., Hillier S., Krohn M.A., Platt R., Lee M.L. et al. Invasive disease due to group B streptococcus in pregnant women and neonates from diverse population groups. Clin. Infect. Dis. 2000; 30(2): 276-81.
  16. Carlough M.C., Crowell K. How should we manage infants at risk for group B streptococcal disease? J. Fam. Pract. 2003; 52: 406-9.
  17. Cloherty J.P., Eichenwald E C., Stark A.R., eds. Manual of neonatal care. Philadelphia, PA: Lippincott Williams & Wilkins; 2008. 285 p.
  18. Luck S., Torny M., d’Agapeyeff K., Pitt A., Heath P., Breathnach A., Russell A.B. Estimated early-onset group B streptococcal neonatal disease. Lancet. 2003; 361(9373): 1953-4.
  19. Apgar B.S., Greenberg G., Yen G. Prevention of group B streptococcal disease in the newborn. Am. Fam. Physician. 2005; 71(5): 903-10.
  20. Benitz W.E., Gould J.B., Druzin M.L. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics. 1999; 103: 77.
  21. Nandyal R.R. Update on group B streptococcal infections: perinatal and neonatal periods. J. Perinat. Neonatal Nurs. 2008; 22(3): 230-7.
  22. Chen K.T., Puopolo K.M., Eichenwald E.C., Onderdonk A.B., Lieberman E. No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B streptococcus in the era of intrapartum antibiotic prophylaxis. Am. J. Obstet. Gynecol. 2005; 192(4): 1167-71.
  23. Оганян К.А. Течение и исход беременности при колонизации мочеполового тракта женщин стрептококками группы B и D: Автореф. дис.. канд. мед. наук. СПб.; 2008.
  24. Bromiker R., Ernest N., Meir M.B., Kaplan M., Hammerman C., Schimmel M.S., Schlesinger Y. Correlation of bacterial type and antibiotic sensitivity with maternal antibiotic exposure in early-onset neonatal sepsis. Neonatology. 2013; 103(1): 48-53.
  25. Платонов А.Е., Шипулин Г.А., Тютюнник Е.Н., Платонова О.В. Генодиагностика бактериальных менингитов и генотипирование их возбудителей: Пособие для врачей. М.; 2001. 29 с.
  26. Buonocore G., Bracci R., Weindling M., eds. Neonatology: a practical approch to neonatal diseases. Springer; 2012. 1380 p.
  27. Cezarino B.N. Yas sepsis by nested-PCR of residual urine samples. Braz. J. Microbiol. 2008; 39: 21-4.
  28. Van Dyke M.K., Phares C.R., Lynfield R., Thomas A.R., Arnold K.E., Craig A.S. et al. Evaluation of universal antenatal screening for group B streptococcus. N. Engl. J. Med. 2009; 360(25): 2626-36.
  29. Berner R. Infektionen durch Gruppe-B-Streptokokken in der Neonatal periode. Monatsschr. Kinderheilkd. 2003; 151: 373-83.
  30. Seidel H.M., Rosenstein B.J., Pathak A., McKay W.H., eds. Primary care of the newborn. Saunders Elsevier Publ.; 2006: 366-7.
  31. Шуляк Б.Ф. Инфекция стрептококка группы В, методы ее лабораторной диагностики и профилактики. Медицинский алфавит. 2010; 2: 47-53.
  32. Regan J.A., Klebanoff M.A., Nugent R.P., Eschenbach D.A., Blackwelder W.C., Lou Y. et al. Colonization with group B streptococci in pregnancy adverse outcome. VIP Study Group. Am. J. Obstet. Gynecol. 1996; 174(4): 1354-60.
  33. Heath P.T., Balfour G., Weisner A.M., Efstratiou A., Lamagni T.L., Tighe H. et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet. 2004; 363(9405): 292-4.
  34. Thomas W., Speer C.P. Chorioamnionitis: important risk factor or innocent bystander for neonatal outcome? Neonatology. 2011; 99: 177-87.
  35. Рооз Р., Генцель-Боровичени О., Проките Г. Неонатология. Практические рекомендации: Пер. с нем. Минск: Медицинская литература; 2011. 592 с.
  36. Wiswell T.E., Baumgart S., Gannon C.M., Spitzer A.R. No lumbar puncture in the evaluation for early neonatal sepsis: will meningitis be missed? Pediatrics. 1995; 95: 803-6.
  37. Козлов В.В., Веселов А.В. Амоксициллин/сульбактам -новый представитель ингибиторозащищенных бета-лактамов. Клиническая микробиология и антимикробная терапия. 2006; 8(2): 173-85.
  38. Нисевич Н.И., Учайкин В.Ф. Инфекционные болезни у детей. М.; 1990. 249 с.
  39. Kenyon S., Taylor D.J., Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet. 2001; 357: 979-88.
  40. Chung M.Y., Ko D.J., Chen C.C., Huang C.B., Chung C.H., Chen F.S., Hwang K.P. Neonatal group B streptococcal infection: a 7-year experience. Chang Gung Med. J. 2004; 27(7): 501-8.
  41. Kenyon S., Boulvain M., Neilson J.P. Antibiotics for preterm rupture of membranes. Cochrane Database Syst. Rev. 2003; (2): CD001058.
  42. Ортенберг Э.А., Ушакова М.А., Вешкурцева И.М., Рожаев М.В. Ингибиторозащищенные бета-лактамы: место в современных схемах антибактериальной терапии. Клиническая микробиология и антимикробная терапия. 2005; 7(4): 393-402.
  43. Садова Н.В., Заплатников А.Л., Шипулина О.Ю., Пиксасова О.В., Фомина С.Г., Подкопаев В.Н. Перинатальная инфекция, вызванная стрептококками группы В. Русский медицинский журнал. 2010; 18(1): 25-7.
  44. Schrag S., Gorwitz R., Fultz-Butts K., Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm. Rep. 2002; 51(RR-11): 1-22.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies